Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Pyridostigmine Bromide 2Prednisone 2telitacicept 1rozanolixizumab 1ravulizumab 1efgartigimod alfa 1Prednisolone 1Immunoglobulins, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Myasthenia Gravis × Immunoglobulins, Intravenous × Clear all
NCT01179893 2010-08-11

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

University Health Network, Toronto

Phase 4 Completed
87 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡